Clearmind Medicine Inc — Cash Flow (NASDAQ:CMND)

Financials

Cash from operating activities —-6.3 M-4.86 M-4.73 M — Cash from investing activities —-26.23 K-238.1 K-542.02 K — Cash from financing activities —11.66 M6.25 M2.62 M — Free cash flow —-6.3 M-4.86 M-4.73 M —

新闻

Clearmind Medicine股价在I/IIa期试验安全性更新后下跌

Clearmind Medicine stock falls after Phase I/IIa trial safety update

Clearmind在酒精使用障碍药物试验中报告积极安全结果

Clearmind公布酒精使用障碍治疗试验的积极安全数据

Clearmind reports positive safety results in AUD drug trial

Clearmind reports positive safety data from AUD treatment trial

Clearmind Medicine股价在与Polyrizon达成鼻内给药协议后飙升

Clearmind Medicine stock surges after Polyrizon intranasal delivery deal

Clearmind与Polyrizon合作开发MEAI鼻内给药配方

Clearmind partners with Polyrizon to develop intranasal MEAI formulation

Polyrizon将开发Clearmind的MEAI药物鼻内给药配方

Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug